Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

E-cadherinÀÇ ¹ßÇöº¯È­°¡ ½Å¼¼Æ÷¾Ï ȯÀÚÀÇ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ Prognostic Significance of E-cadherin Expression in Renal Cell Carcinoma

´ëÇѺñ´¢±â°úÇÐȸÁö 1996³â 37±Ç 11È£ p.1221 ~ 1226
±èÅ¿µ, ¼­°æ±Ù, ·ùÈñ¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÅ¿µ (  ) 
Áß¾Ó´ëÇб³

¼­°æ±Ù (  ) 
Áß¾Ó´ëÇб³
·ùÈñ¼ö (  ) 
Áß¾Ó´ëÇб³

Abstract


E-cadherin is one of intercellulaqr adhesion molecules, and it has been demonstrated that E-cadhedrin acts as an invasion suppressor in vitro and loss of its expression is an important prognostic factor in human maljignancies. However the
prognostic
value of loss of expression of E-cadhedrin in renal cell carcinoma (RCC) remains to be defined.
We herein immmunohistochemically examined the dexpression of E-cadhedrin in paraffinembedded tissues of 43 patients with RCC to investigdate the prognostic value of loss of expression of E-cadherin. Twenty three of 43 patients (54.5%) showed loss
of
expression of E-cadherin. There were significant correlations between loss of expression of E-cadherin and histopathologic grade, Robson stage, T stage, N stage and M stage (all p<0.05). Patients with loss of expredssion of E-cadherin shlowed
significantly decreased 2 year disease free survival as compared with those with normal expression of E-cadherin (p<0.001).
These results suggest that loss of expression of E-cadherin has a ominous prognostic value in patients with RCC.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS